DELIVERY ORDER
Active75N94026F00001
Department of Health and Human Services › National Institutes of Health › NATIONAL INSTITUTES OF HEALTH NICHD
$2.5M
obligated · signed 1 month ago
THE CONTRACTOR SHALL COORDINATE, MAINTAIN AND MANAGE NICHD PARTICIPATING SITES FOR IMPAACT 2050 / CREATE - PHASE IV STUDY OF THE PHARMACOKINETICS OF LONG-ACTING INJECTABLE CABOTEGRAVIR AND RILPIVIRINE IN PREGNANT AND POSTPARTUM WOMEN WITH HIV IN THE
Performance timeline
Start
Sep 28, 2026
End
Sep 27, 2031
with all options
Loading status
Estimated start: Sep 27, 2030
WESTAT, INC.
Contract 75N94026F00001
UEI
NVUWAFWQ57S5
Parent Company
WESTAT, INC.
Capabilities & Certifications
Headquarters Location
Congressional District: 08
Current Obligation
$2,502,640
Base + Exercised Options
$2,502,640
Total Ceiling Value
$2,502,640
Contract Type
COST PLUS FIXED FEE
Multi-Year Contract
NO
NAICS
RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
PSC
HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH
Place of Performance
Congressional District: 08
Awarding Agency
Top-tier agency
National Institutes of Health
Sub-tier agency
NATIONAL INSTITUTES OF HEALTH NICHD
Office
Funding Agency
Top-tier agency
National Institutes of Health
Sub-tier agency
NATIONAL INSTITUTES OF HEALTH NICHD
Office
Contract Vehicle
75N94023D00001
IDCDepartment of Health and Human Services
Award type: SINGLE AWARD
Solicitation procedures, competition exceptions, labor standards and account totals.